feed,title,long_url,short_url
Benzinga,This Inflammatory Disease Focused Stock Is Well Positioned For $12B Crohn's Disease Market,https://benzinga.com/analyst-ratings/analyst-color/22/08/28522669/this-inflammatory-disease-focused-stock-is-well-positioned-for-12b-crohns-disease-m,https://bit.ly/3c64i7Y
